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Introduction: The outcome of the effects of
transitioning to minimalist running shoes is a topic of
interest for runners and scientists. However, few
studies have investigated the longer term effects of
running in minimalist shoes. The purpose of this
randomised controlled trial (RCT) is to investigate the
effects of a 26 week transition to minimalist shoes on
running performance and injury risk in trained runners
unaccustomed to minimalist footwear.
Methods and analysis: A randomised parallel
intervention design will be used. Seventy-six trained
male runners will be recruited. To be eligible, runners
must be aged 18–40 years, run with a habitual rearfoot
footfall pattern, train with conventional shoes and have
no prior experience with minimalist shoes. Runners
will complete a standardised transition to either
minimalist or control shoes and undergo assessments
at baseline, 6 and 26 weeks. 5 km time-trial
performance (5TT), running economy, running
biomechanics, triceps surae muscle strength and lower
limb bone mineral density will be assessed at each
time point. Pain and injury will be recorded weekly.
Training will be standardised during the first 6 weeks.
Primary statistical analysis will compare 5TT between
shoe groups at the 6-week time point and injury
incidence across the entire 26-week study period.
Ethics and dissemination: This RCT has been
approved by the Human Research Ethics Committee of
the University of South Australia. Participants will be
required to provide their written informed consent prior
to participation in the study. Study findings will be
disseminated in the form of journal publications and
conference presentations after completion of planned
data analysis.
Trial registration number: This RCT has been
registered with the Australian New Zealand Clinical
Trials Registry (ACTRN12613000642785).
INTRODUCTION
The effects of running in minimalist shoes is
a topic of interest for runners and for scien-
tists.1–7 Running in minimalist shoes can
cause runners to run with a more
plantar-ﬂexed ankle at initial contact and
adopt a forefoot footfall (FF) pattern,4 6 7
increase stride rate,1 7 reduce stride length,1
increase ankle plantar-ﬂexor moments and
decrease knee extensor moments,4 and
improve running economy.2 Although ath-
letes and coaches may be interested in the
potential for minimalist shoes to improve
running performance, there is also some evi-
dence that minimalist shoes increase injury
risk.5 However, few studies have included a
prospective longitudinal follow-up of runners
who changed from conventional to minimal-
ist running shoes.5 7–11 At present, runners,
coaches and clinicians attempting to make a
more informed purchase or prescription of
minimalist shoes are required to base their
decision on predominantly acute studies with
no longitudinal follow-up.1 3 4 6
The authors are not aware of any consen-
sus on what should be an appropriate
follow-up period to investigate the long-term
effects of minimalist shoes. However, the few
studies that have included a prospective lon-
gitudinal follow-up of runners who changed
to minimalist shoes have used follow-up
periods of only 4–12 weeks.5 7–11 These
Strengths and limitations of this study
▪ This is the first study to investigate the effects of
minimalist footwear over longer than a 3-month
period and the first to include a measure of
running performance.
▪ The standardised gradual transition to minimalist
shoes from 0% to 100% of weekly running will
inform runners, coaches and clinicians of the
effect of these shoes across the entire transi-
tional period.
▪ Limitations of the study are the inclusion of only
male runners aged 18–40 years and the inclu-
sion of only one minimalist shoe group.
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studies found that, following the transition to minimalist
shoes, runners improved running economy,7 reduced
peak pressure under the heel9 and increased intrinsic
foot muscle cross-sectional area,11 but experienced
increased calf and shin pain,5 8 increased foot bone
marrow oedema10 and a higher injury rate.5 It has been
hypothesised that these effects of minimalist shoes result
from runners adopting a FF pattern, which causes
increased loading of musculoskeletal structures at the
foot and ankle.11–13 If an appropriate, gradual transition
to minimalist shoes can be made, it might be possible to
derive beneﬁcial training adaptations from this
increased loading.7 11 However, if the increased loading
is too rapid, pain and injury may result from the
increased forces experienced by the ankle plantar-ﬂexor
muscles.4 5 Indeed, the only study to investigate the
effect of transitioning to minimalist shoes on injury risk
reported greater calf pain and a higher incidence of
injury for two different minimalist shoes (20% and 38%)
compared to conventional shoes (13%).5
Choice of running shoe is an important issue for dis-
tance runners who view minimalist shoes as a means for
enhancing running performance but have concerns
about the potential for minimalist shoes to cause injury.14
Avoiding injuries resulting from minimalist shoes is
important for runners to minimise the economic burden
associated with medical treatment and absenteeism from
work, as well as to maximise the positive health effects of
maintaining an active lifestyle.15 This issue is particularly
relevant given the popularity of running, which is per-
formed by 10% of the Australian population.16 In order
to provide runners with sufﬁcient instructions on how to
implement minimalist shoes, further longitudinal studies
investigating methods for transitioning to minimalist
shoes over longer periods are needed. Current longitu-
dinal studies involving minimalist shoes have either been
limited to follow-up periods of 12 weeks or less,5 7–11 have
only transitioned runners to using minimalist shoes for
up to 60% of weekly running,5 7 11 have not used standar-
dised methods for transitioning to minimalist shoes10 or
have not investigated injury incidence7–11 and running
performance,5 8–11 which are the two most signiﬁcant
outcomes for runners interested in minimalist shoes.14
Primary objective
The purpose of this randomised controlled trial (RCT)
is to investigate the effects of a 26-week transition to
minimalist shoes compared to conventional shoes on
running performance and injury risk in trained runners
unaccustomed to minimalist footwear. It is hypothesised
that transitioning to minimalist shoes will have beneﬁts
for running performance but be associated with an
increased risk of injury. The increased risk of injury is
expected to result from the increased forces experi-
enced by the ankle plantar-ﬂexor muscles when running
with a ﬂatter foot position at initial contact in the min-
imalist shoe.
METHODS
This study protocol was developed according to the 2013
SPIRIT (Standard Protocol Items: Recommendations for
Interventional Trials) statement.17 The study will use a
two-arm RCT design with 6 and 26-week follow-up. Data
collection will take place at the University of South
Australia. The RCT has been registered with the
Australian New Zealand Clinical Trials Registry. Trial
registration data are shown in table 1. Participants will
be recruited from a sample of convenience on a volun-
teer basis. This study will be advertised at local univer-
sities, running clubs and running events. To assist with
participant retention, participants will be provided with
a $100 shoe voucher if they successfully complete the
26-week study commitment. Participants who withdraw
from the study due to injury will also receive the $100
shoe voucher after independent assessment of the injury
by a registered physiotherapist or medical practitioner
not associated with the study.
Study population
Male runners will be recruited to avoid potential gender
effects on running biomechanics.18 Only runners aged
18–40 years will be recruited because that is the most
popular age group for participation in running in
Australia.16 Participants will be required to run a
minimum of 15 km per week3 (this will minimise the
risk of injuries resulting from a lack of familiarity with
regular running19), be able to complete a 5 km tread-
mill time trial (5TT) in ≤23 min (95% of runners repre-
sented by the cohort of male endurance-trained runners
in a study by Laursen et al20 would complete a 5TT in
less than 23 min, ie, mean 5TT +2 SDs was 23 min),
train with conventional running shoes, have no prior
experience running in shoes with reduced cushioning,
drop height and mass, run with a rearfoot footfall (RF)
pattern at the time of enrolment in the study (typical of
89% of runners21) and have no current or recent
(<3 months) musculoskeletal injury. Participants will be
excluded if they have a history of invasive surgery to the
back, pelvis or lower extremities in the previous year or
if they use orthotics in their running shoes, because
orthotics will not ﬁt inside the minimalist shoe. Footfall
pattern will be determined from overground running
trials at a self-selected running speed in participants’
own running shoes ﬁlmed at 200 Hz using a high-speed
digital camera (Basler Pilot, Ahrensburg, Germany) to
ensure only habitual RF runners are recruited.
Sample size
An a priori power calculation determined that 50 partici-
pants are required to detect a Cohen’s d effect size of 0.3
for the primary outcome (5TT performance) at 6-week
follow-up with 80% power and a 5% signiﬁcance level
using analysis of covariance (ANCOVA). This calculation
was performed using the formula described by Borm et al22
and South Australian 5 km road race results recorded in
2011 and 2012 (average race time 1139±140 s). The 0.3
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effect size was based on the 2.4–5.8% improvement (mean
improvement 3.6%) in running economy observed for
runners training with or experienced with minimalist
shoes6 7 23 and a corresponding 10.6 m/min improvement
in average race pace (44 s improvement in average race
time) estimated by Burkett et al.24 To allow for a 20% drop
out rate and a 25% rate of injury5 during the 6-week
follow-up period, it is expected that 76 participants will
need to be recruited. An additional 12 participants will be
recruited and will complete all outcome assessments on
two separate occasions in their own shoes to determine
test-retest reliability.
Study protocol
Participants will attend a familiarisation session in the
week prior to their anticipated start date. During this
session, information about previous injury and shoe use
will be collected, participants will complete 30 min
treadmill familiarisation, footfall pattern will be assessed
and a 5TT will be completed. Randomisation to shoe
group will be via a process of minimisation,25 using 5TT
performance times obtained during familiarisation as
the minimisation variable and a 1:1 allocation ratio.
Allocation via minimisation offers the only acceptable
alternative to simple and restricted randomisation,26 and
is more effective at balancing the collective attributes of
intervention groups in small samples than traditional
methods of randomisation.27 Allocation of participants
will be performed by one of the investigators (JDB) who
will not be involved directly in data collection, but it will
not be possible to blind outcome assessors to participant
shoe condition during testing. Experimental testing ses-
sions will be undertaken for each shoe condition at base-
line, at 6-week follow-up and at 6-month follow-up.
Outcomes assessed in order of assessment at each test
session will be overground running kinematics and
kinetics, treadmill running economy, bone mineral
density (BMD), 5TT performance and muscle strength.
A participant timeline is shown in ﬁgure 1. All testing
sessions will be performed at the same time of the day.
Table 1 Trial registration data
Data category Information
Primary registry and trial
identifying number
https://www.anzctr.org.au ACTRN12613000642785
Date of registration in primary
registry
7th June, 2013
Secondary identifying numbers None
Source of monetary or material
support
University of South Australia
Primary sponsor University of South Australia
Contact person: JDB ( jon.buckley@unisa.edu.au)
Secondary sponsor None
Contact for public queries JTF ( joel.fuller@mymail.unisa.edu.au)
Contact for scientific queries JTF ( joel.fuller@mymail.unisa.edu.au)
Public title The effect of footwear on running performance and injury risk
Scientific title In distance runners, do lightweight running shoes, compared to standard running shoes,
improve running performance and reduce risk of injury?
Countries of recruitment Australia
Health problem studied Running-related injury
Interventions Minimalist shoe (Asics Piranha SP4)
Conventional shoe (Asics Gel Cumulus-14, 15 or 16)
Key inclusion and exclusion
criteria
Inclusion criteria: male, 18–40 years, running ≥15 km per week, with habitual rearfoot
footfall and able to run a 5 km time trial in <23 min
Exclusion criteria: prior experience with minimalist shoes, use of orthotics, having a current
or recent (<3 months) musculoskeletal injury or history of recent (<12 months) invasive
surgery that affected running
Study type Randomised controlled trial
Date of first enrolment 24th June 2013
Target sample size 76
Recruitment status Closed: follow-up continuing
Primary outcome 5 km time trial performance (time point: 6 weeks)
Key secondary outcomes Injury incidence (time fame: 6 months)
5 km time trial performance (time point: 6 months)
Running economy (time point: 6 weeks and 6 months)
Running biomechanics (time point: 6 weeks and 6 months)
Triceps surae strength (time point: 6 weeks and 6 months)
Bone mineral density (time point: 6 weeks and 6 months)
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Participants will be required to not complete any train-
ing on the day of testing and remain fasted from food
(water permitted ad libitum) in the 3 h prior to testing.
Shoe conditions
Participants allocated to the control condition will run
in conventional running shoes (Asics Gel Cumulus-14,
15 or 16; mass 324 g/shoe; heel drop 9 mm) and partici-
pants allocated to the minimalist shoe condition will run
in lightweight racing ﬂats (Asics Piranha SP4; mass
125 g/shoe; heel drop 5 mm). Mass is reported for an
average US size 9 (European size 42.5) shoe.
Participants will be instructed to complete only 5% of
running in their allocated shoes on each day that they
run in the ﬁrst week. This amount will then be increased
by 5% each week until week 20, when participants will
complete 100% of running in the allocated shoes. From
weeks 20–26, runners will perform all running in their
allocated shoe condition.
To investigate how the runners perceive the comfort
of the two shoe conditions, they will complete an assess-
ment of shoe comfort for their respective shoe condition
at the beginning of each testing session. Assessments of
shoe comfort will be made using a 100 mm visual ana-
logue scale (VAS) with anchors “not comfortable at all”
on the left hand end and “most comfortable imagin-
able” on the right.28 Shoe comfort will be assessed
before and following a 2 min submaximal run on a
motorised treadmill at self-selected running speed
(Model 645, Quinton Instrument Co, Washington,
USA). Four familiarisation comfort assessments will be
used to achieve stability of shoe comfort results.28
Training programme
Running training will be standardised during the ﬁrst
6 weeks of the study so that relative training intensity
and volume will be the same for all participants.
Training intensity will be prescribed relative to the peak
heart rate (HRpeak) achieved during the 5TT.
Participants will monitor training intensity throughout
the training programme using a heart rate monitor
(Polar F1 heart rate monitor, Polar Electro Oy, Kempele,
Finland). The training programme is adapted from a
6-week training programme used by Billat et al29 that was
shown to increase VO2max by 3.6% in trained runners.
The training programme is described in table 2. During
weeks 7–26, training will not be standardised and partici-
pants will complete their usual training to evaluate the
effects of the shoe under non-controlled conditions so
as to provide ecologically valid outcome data, but the
transition to the allocated shoe will continue to be
increased by 5% per week during this period until parti-
cipants are completing 100% of training in the allocated
shoe. Adherence to training and shoe allocation will be
monitored using a participant training diary.
Participants reporting an injury during the study period
will be advised to stop the gradual increase in allocated
shoe use until they have recovered. Injured participants
will be invited to have their injury assessed and treated
at the University of South Australia physiotherapy clinic.
No study investigators will be involved in the assessment
or treatment of injured participants.
Running kinematics and kinetics
Running kinematics and kinetics will be assessed during
overground running trials performed at 18 km/h±10%
over a 40 m runway. Consistency of running speed will
be monitored using photoelectric sensors (SpeedLight
V2, Swift Performance Equipment, Queensland,
Australia). Marker trajectories will be measured using a
12 camera VICON MX F20 system (Vicon, Oxford, UK)
sampling at 300 Hz. Ground reaction force will be mea-
sured using four force platforms aligned in series and
sampling at 1200 Hz. Each participant will be required
Figure 1 Participant timeline (BMD, bone mineral density; ITT, intention-to-treat; RE, running economy; 5TT, 5 km treadmill time trial).
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to complete ﬁve successful trials. A trial will be consid-
ered successful if the full plantar surface of the foot con-
tacts the force platform in between the pylons of the
force platform at the prescribed running speed without
obvious modiﬁcation of gait. Participants will not be pro-
vided with any instructions in regard to contacting the
force platform. Instead, the runway starting point will be
adjusted as needed to facilitate a successful trial.
A full body marker set-up will be used and will include
the feet, shanks, thighs, pelvis, trunk (including head),
upper arms and lower arms (including hands).
Spherical retroreﬂective calibration markers will be used
to deﬁne the position and orientation in space (POSE)
of each segment, and will be placed over the ﬁrst and
ﬁfth metatarsal head, lateral and medial malleolus,
lateral and medial femoral epicondyle, greater trochan-
ter, anterior superior iliac spine, posterior superior iliac
spine C7 spinous process, acromioclavicular joint, lateral
and medial humeral epicondyle, and radial and ulnar
styloid process. Tracking markers will be used to track
the POSE of each segment. A minimum of three non-
collinear markers will be used to track each segment in
six degrees of freedom. This marker set-up will be used
to investigate footfall pattern as well as kinematics and
kinetics at the knee and ankle.
Running economy
Participants will complete a 5 min warm-up on the tread-
mill at 8 km/h. Running economy will then be assessed
during three 6 min submaximal runs on the treadmill at
11, 13 and 15 km/h in a ﬁxed order. Running economy
will be assessed by indirect calorimetry (True One,
ParvoMedics, Utah, USA) and expressed as the rate of
energy expenditure (REE; kJ/min) during the ﬁnal 60 s
of each 6 min run. Participant data will be excluded if
the respiratory exchange ratio (RER) increases above 1
during the ﬁnal 60 s or a steady state of oxygen con-
sumption is not achieved.
Spatiotemporal parameters
Force-sensitive resistors (FSR) will be placed underneath
the heel and forefoot regions of each shoe, and used to
assess footfall pattern, stride rate and stride length
during each 6 min run. Foot contacts will be recorded
wirelessly at 2000 Hz using a Delsys Trigno system
(DelSys Inc, Natick, USA). Runners will be classiﬁed
with a RF pattern if initial contact is made with the FSR
positioned at the heel or a FF pattern if initial contact is
made with the FSR positioned at the forefoot. Footfall
pattern will be assessed throughout each 6 min run and
classiﬁcation will be based on the mode (ie, whichever
pattern is most frequent) during the ﬁnal 60 s. Stride
rate (strides per minute) will be considered the number
of right foot contacts recorded during the ﬁnal 60 s of
each 6 min run. Average stride length will be calculated
using the following equation:
SL ¼ ST V
SL is the stride length, ST the time taken for each stride
(right foot contact to right foot contact) and V the
treadmill speed30 from the known distance covered
during the 60 s because speed will remain ﬁxed. Footfall
pattern, stride length and stride rate computations will
be performed using a custom written code in MATLAB
(R2013a, MathWorks, Massachusetts, USA).
5 km treadmill time trial
Running endurance performance will be assessed using
a 5TT on a motorised treadmill set at 0% grade.
Participants will be instructed to complete the 5TT in
the fastest possible time and will be free to adjust the
treadmill speed throughout the test. Starting speed will
remain constant across testing sessions and will be
selected by participants prior to completion of their
baseline 5TT. Participants will be blinded to treadmill
speed and time throughout performance of the 5TT.
Table 2 Six-week standardised running training programme
Training session duration (min)
Week Method Day 1 Day 2 Day 3 Day 4 Day 5 Day 6 Day 7
1 LSD – 50 – – 50 – –
HIIT 3×10 – – 2×15 – – –
2 LSD – 50 – – 50 – –
HIIT 3×12 – – 2×18 – – –
3 LSD – 50 – – 50 – –
HIIT 3×14 – – 2×21 – – –
4 LSD – 50 – – 50 – –
HIIT 3×16 – – 2×24 – – –
5 LSD – 50 – – 50 – –
HIIT 3×18 – – 2×27 – – –
6 LSD – – 40 – 40 – –
HIIT 3×20 – – – – – –
LSD, long slow distance running at 65–80% peak heart rate (HRpeak); HIIT, high-intensity interval training running at 85–90% HRpeak. Intervals
separated by 5 min of walking.
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Peak oxygen consumption during the 5TT will be
assessed by indirect calorimetry.
Bone mineral density
BMD of the right proximal tibia, calcaneus and metatar-
sals will be measured by dual X-ray absorptiometry
(Lunar Prodigy, General Electric Corporation, Madison,
USA) using two separate scans. These peripheral sites
were chosen for the assessment of BMD because it was
hypothesised that they would be most likely to change in
response to the potential alterations in running bio-
mechanics that can result from running in minimalist
shoes.4 6 7 For assessment of the tibia and calcaneus, par-
ticipants will be positioned in a side lying position.31 For
assessment of the metatarsals, participants will be posi-
tioned in an upright, seated position with the foot in the
plantar position.32 For each participant, goniometer
measurements for the knee and ankle in the sagittal
plane will be recorded and standardised between scans
to help reproduce the same scan position.
Muscle strength
Muscle strength assessment of the triceps surae muscle
group will be performed on an isokinetic dynamometer
(Biodex System 4, Biodex Medical Systems, New York,
USA) with participants in a reclined seated position with
knees positioned in 20–30° ﬂexion. Peak isometric
torque will be measured with the ankle positioned in the
anatomical neutral position and deﬁned as the peak
torque achieved during the better of two 5 s efforts. Peak
concentric torque (PCT) and peak eccentric torque
(PET) will be measured at an angular velocity of 30°/s.
Two sets of three repetitions will be performed for both
PCT and PET measurements, with the peak torque
achieved across repetitions considered the participant’s
PCT and PET. Torque data will be sampled at 1000 Hz
using a PowerLab data acquisition system (PowerLab
16/30, ADInstruments, Bella Vista, Australia).
Pain and injury monitoring
Pain will be assessed using a study diary for seven
regions of interest using a 100 mm VAS with anchor
points consisting of ‘no pain’ on the left hand end and
‘worst pain’ on the right hand end. Regions of interest
will include the foot, ankle, calf, shin, knee, thigh and
lumbopelvic area. At the end of each week, participants
will be asked to record the worst running-related pain
that they experienced during the previous 7 days for
each of the 7 regions of interest. A difference in VAS
score of 10 mm will be considered clinically signiﬁcant.33
An injury will be considered to be any musculoskeletal
problem that is attributed by the participant to running.
The problem will need to be severe enough to cause a
reduction in weekly running distance, a visit to a health
professional or the use of medication.34 35 Injuries attrib-
uted to an accident will not be considered. Injury events
will be reported to the University of South Australia
Human Research Ethics Committee who will independ-
ently monitor the safety of the study interventions.
Data management
Outcome data will be entered electronically and stored
in a password protected folder on the University of
South Australia network server at the time of collection.
Only study investigators will have access to the data and
investigators will meet weekly to monitor progress of
data collection. All outcome data will be de-identiﬁed
using a participant identiﬁcation numbering system.
Statistical methods
Per-protocol analysis will be used to assess the effect of
shoe group at the end of the 6-week standardised train-
ing programme. Participants unable to complete a
follow-up assessment at the end of the 6-week training
programme due to injury will not be included in the
per-protocol analysis. An ANCOVA will be used to
compare 5TT performance, running kinematics, and
kinetics and muscle strength between shoe groups after
adjusting for baseline time. Running economy and
spatiotemporal parameters will be analysed using a
linear ﬁxed-effects model with independent variables
shoe, speed, time and shoe*speed*time interaction.
Shoe mass will be included as a covariate in the statistical
model for running economy. Cases with missing
running economy data (ie, RER >1.00) will be included
in the model.
Intention-to-treat analysis will be used to assess the
effect of shoe group at the end of the 26-week study
period. 5TT performance, running economy, muscle
strength, BMD, spatiotemporal parameters, and running
kinematics and kinetics will be compared between shoe
groups using a linear ﬁxed-effects model with independ-
ent variables shoe, time and shoe*time interaction. The
independent variables speed and shoe*speed*time will
be included in the statistical models for running
economy and spatiotemporal parameters. Shoe mass will
be included as a covariate in the statistical model for
running economy. Cases with missing running economy
data (ie, RER >1.00) will be included in the model.
Injury rate will be analysed by log binomial generalised
linear model with independent variable group.
Sensitivity analysis will be undertaken to determine
whether the effect of shoes is inﬂuenced by adherence
to training programme and training volume, by includ-
ing adherence and training volume as covariates. All stat-
istical analysis will be performed in SPSS (V.22, IBM,
New York, USA). Statistical signiﬁcance will be assumed
for p<0.05.
ETHICAL CONSIDERATIONS
This protocol has received ethical approval from the
Human Research Ethics Committee of the University of
South Australia. The Ethics Committee will be notiﬁed
of any planned amendments to the original protocol.
6 Fuller JT, et al. BMJ Open 2015;5:e008307. doi:10.1136/bmjopen-2015-008307
Open Access
group.bmj.com on August 16, 2016 - Published by http://bmjopen.bmj.com/Downloaded from 
Amendments will not be made without the prior
approval of the Ethics Committee and all members of
the investigatory team.
JTF will manage all expressions of interests and will
provide all potential participants with a study informa-
tion sheet. At the beginning of the initial familiarisation
session, participants will be briefed on all aspects of the
study and provided with an opportunity to have any
questions answered. Eligible participants will be required
to provide their written informed consent prior to par-
ticipation in the study (see online supplementary
material).
DISSEMINATION OF FINDINGS
Study results will be released to participants in a
de-identiﬁed format. Participants will be provided with a
separate copy of their personal results. Study ﬁndings
will be released to the public in the form of journal pub-
lications and conference presentations.
DISCUSSION
Prospective longitudinal follow-up of runners who
change to minimalist shoes is important to inform
runners, coaches and clinicians about their safety and
efﬁcacy. Although short-term studies are informative for
describing any immediate effects of minimalist shoes on
running parameters, they are not useful for informing
evidence-based prescription for longer term use.36 We
propose to use an RCT to provide high-quality evidence
regarding the efﬁcacy of transitioning from conventional
shoes to minimalist shoes.
There is still no consensus deﬁnition for minimalist
shoes.5 Instead, footwear is considered to be minimalist
if shoe mass, heel drop and cushioning are reduced
compared with conventional running shoes.1 5 Choice
of minimalist shoe is an important consideration for
studies investigating the effects of these shoes. In this
RCT, a racing ﬂat will be used as the minimalist shoe
condition. Racing ﬂats differ from conventional running
shoes by having reduced shoe mass, heel drop and cush-
ioning, and, as such, can be categorised as a form of
minimalist shoe.1 Additionally, racing ﬂats have been
used by runners and coaches in competition for many
years,1 37 and can be considered representative of the
footwear condition that runners used prior to the intro-
duction of the modern conventional running shoe,
which has increased shoe mass, heel drop and cushion-
ing.14 It has been suggested that the introduction of the
modern conventional running shoe may have caused
changes to the natural human running gait and resulted
in an increased injury rate.38 To adequately test this
hypothesis, conventional running shoes should be com-
pared with racing ﬂats, which were the predominant
running shoe available to runners prior to the introduc-
tion of shoe cushioning and heel raise.
It has been proposed that carefully transitioning
from conventional to minimalist running shoes can avoid
injuries attributed to sudden changes in footwear.5 7–11
Several methods have been suggested for making this tran-
sition5 7–11 (table 3), but currently, there is insufﬁcient
evidence available on which to base informed recommen-
dations. The percentage of running performed in minim-
alist shoes during the ﬁrst week of transition has ranged
from 3–33% and has then been progressed each week by
small amounts (table 3).5 7–11 Across studies, runners pro-
gressed the volume of minimalist shoe running by 3–20%
each week (table 3).5 7 8 10 11 This heterogeneity across
Table 3 Methods of transitioning from conventional to minimalist footwear used in the literature
Author Date Minimalist shoe Week 1* Method for transitioning to minimalist footwear*
Giandolini et al8 2013 Salomon Sense S-Lab 33% Increase by 3–17% each week until reaching 100% in
week 4
100% of running performed in minimalist shoes from week
5–12
Ridge et al10 2013 Vibram FiveFingers 3–13% Increase by 3–13% each week until week 3
Participants made further increases as they felt
comfortable during weeks 4–10
Ryan et al5 2013 Vibram FiveFingers
Nike Free V.5.0
19% Gradual increases were made from week 1–12
58% of running performed in minimalist shoes during week
12




7% Increase by <10% each week from week 1–12




2014 Vibram FiveFingers 10% Gradual increases were made from week 1–4
25% of running performed in minimalist shoes during
week 4
Moore et al9 2015 Vibram FiveFingers 3–10
miles
Increase by no more than 20% each week
No running performed in conventional shoes throughout
the transition
*Values indicate percentage of weekly running performed in the minimalist shoe condition.
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studies suggests that it is currently unclear what is an appro-
priate rate of progression for transition to running in min-
imalist shoes. In the present study, runners will use a 5%
per week progression in the amount of time spent running
in minimalist shoes until they reach 100% (by week 20).
They will then continue to run 100% in minimalist shoes
during the ﬁnal 6 weeks of the study. Onset of injury and
weekly pain scores will be used to determine if there is a
threshold amount of running in minimalist shoes that is
associated with an increased risk of injury in runners transi-
tioning from conventional shoes. This will provide import-
ant information to runners, coaches and clinicians who are
planning a transition to minimalist shoes about optimal
transition rates to reduce the risk of injury.
To maximise recruitment and to allow for a longer
follow-up period, as well as in order to achieve eco-
logical validity, this RCT will use a period of non-
standardised training between 6 and 26 weeks of
follow-up, during which participants will perform their
own usual training programme. The outcomes at week
26 are likely to be affected by the different training
regimes followed by participants during this non-
standardised phase between weeks 6 and 26, but any het-
erogeneity of usual training regimes should be balanced
across groups through the randomisation process.
The efﬁcacy of minimalist shoes for improving per-
formance and their safety in terms of injury risk is
thought to be inﬂuenced by the running kinematics that
are adopted when running in this type of footwear.5 7
Running in minimalist shoes has previously been shown
to reduce stride length1 and the amount of ankle dorsi-
ﬂexion at initial ground contact,6 with the latter promot-
ing a FF pattern.4 7 Changing to a FF pattern increases
ankle joint contact forces and plantar-ﬂexor muscle
forces.13 Increased involvement of the ankle plantar-
ﬂexor muscle could result in greater elastic energy
storage and recovery in the Achilles’ tendon, which may
contribute to improved running economy and perform-
ance.4 39 We hypothesise that the increased loading on
these structures may contribute to greater adaptation
with resultant greater increases in performance in
response to training.7 However, these unaccustomed
high forces could also increase risk of injury until sufﬁ-
cient adaptation has occurred in muscular and articular
tissue.5 10 11 13 Previous research has observed changes
in muscle and bone tissue when transitioning to minim-
alist shoes over 10–12 weeks,10 11 and the 26 week transi-
tion used in the present study will add to this
knowledge. Additionally, examining the effects of min-
imalist shoes on running biomechanics, muscle strength,
BMD and running economy in the present study will
allow for investigation of the factors underlying any
effects on performance and/or injury to be explored.
CONCLUSION
In conclusion, this RCT will provide high-quality evi-
dence regarding the effect on running performance of
transitioning from conventional to minimalist shoes,
which is currently lacking in the ﬁeld of running foot-
wear research. Additionally, observation of injury rates
during this transition will be used to inform the design
of larger studies investigating the effect of minimalist
shoes on injury risk. The 26-week longitudinal follow-up
period used in this study will be the longest prospective
follow-up of runners changing to minimalist shoes that
has been reported in the literature to date. Assessments
of running biomechanics, muscle strength and BMD will
allow this RCT to explore the mechanisms underlying
any effects of minimalist shoes on running performance
and/or injury.
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